Skip to content

Glycocalyx During Normothermic Machine Perfusion

Glycocalyx Damage During Normothermic Graft Perfusion in Orthotopic Liver Transplantation - A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04764266
Enrollment
30
Registered
2021-02-21
Start date
2021-02-10
Completion date
2024-02-01
Last updated
2024-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glycocalyx, Liver Transplantation

Brief summary

An organ intended for transplantation is normally stored on ice (cold storage, CS) after explantation from the donor. During this storage process, damage to the endothelial glycocalyx occurs. It is known from numerous studies that the integrity of the endothelial glycocalyx is necessary for organ function. Normothermic machine perfusion is an alternative storage method for explanted livers, where the graft is perfused with warm blood. This study aims to clarify the influence of normothermic machine perfusion on endothelial glycocalyx damage of the graft.

Interventions

DIAGNOSTIC_TESTHeparansulfate and Syndecan 1

Blood samples will be collected from the patient at 5 different time points. Three perfusate samples will be collected during normothermic machine perfusion (4,9ml each).

Sponsors

Medical University Innsbruck
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* First deceased donor liver transplantation receiving a graft after normothermic machine perfusion * Recipient age \>18 years * Written informed consent

Exclusion criteria

* Age \< 18 years

Design outcomes

Primary

MeasureTime frameDescription
Syndecan 1 level during normothermic machine perfusion24 hoursSyndecan 1 level at the end of normothermic perfusion compared to the beginning of perfusion
Heparansulfate level during normothermic machine perfusion24 hoursHeparansulfate level at the end of normothermic perfusion compared to the beginning of perfusion

Secondary

MeasureTime frameDescription
Syndecan 1 after transplantation72 hoursChange of Syndecan 1 level after transplantation
Heparansulfate level after transplantation72 hoursChange of Syndecan 1 level after transplantation

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026